These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3392683)

  • 41. Somatostatin receptors mediating inhibition of basal and stimulated electrogenic ion transport in rat isolated distal colonic mucosa.
    McKeen ES; Feniuk W; Humphrey PP
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):402-11. PubMed ID: 8532068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PYY preference is a common characteristic of neuropeptide Y receptors expressed in human, rat, and mouse gastrointestinal epithelia.
    Holliday ND; Pollock EL; Tough IR; Cox HM
    Can J Physiol Pharmacol; 2000 Feb; 78(2):126-33. PubMed ID: 10737675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for in vivo interactions between neuropeptide Y-related peptides and sigma receptors in the mouse hippocampal formation.
    Bouchard P; Dumont Y; Fournier A; St-Pierre S; Quirion R
    J Neurosci; 1993 Sep; 13(9):3926-31. PubMed ID: 8366352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of various neuropeptide Y/peptide YY fragments on electrically-evoked contractions of the rat vas deferens.
    Grundemar L; Håkanson R
    Br J Pharmacol; 1990 May; 100(1):190-2. PubMed ID: 2372659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning.
    Goumain M; Voisin T; Lorinet AM; Ducroc R; Tsocas A; Rozé C; Rouet-Benzineb P; Herzog H; Balasubramaniam A; Laburthe M
    Mol Pharmacol; 2001 Jul; 60(1):124-34. PubMed ID: 11408607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropeptide Y and peptide YY inhibit excitatory synaptic transmission in the rat dorsal motor nucleus of the vagus.
    Browning KN; Travagli RA
    J Physiol; 2003 Jun; 549(Pt 3):775-85. PubMed ID: 12730340
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Actions of peptide YY and neuropeptide Y on chief cells from guinea pig stomach.
    Raufman JP; Singh L
    Am J Physiol; 1991 Jun; 260(6 Pt 1):G820-6. PubMed ID: 1647673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.
    Valet P; Berlan M; Beauville M; Crampes F; Montastruc JL; Lafontan M
    J Clin Invest; 1990 Jan; 85(1):291-5. PubMed ID: 2104880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spinal and peripheral modulation of gastric acid secretion and arterial pressure by neuropeptide Y, peptide YY, and pancreatic polypeptide in rats.
    Wager-Pagé SA; Rosenbaum G; Veale WL; Davison JS
    Peptides; 1993; 14(6):1299-308. PubMed ID: 8134313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of peptide YY with rat intestinal epithelial plasma membranes: binding of the radioiodinated peptide.
    Laburthe M; Chenut B; Rouyer-Fessard C; Tatemoto K; Couvineau A; Servin A; Amiranoff B
    Endocrinology; 1986 May; 118(5):1910-7. PubMed ID: 3009142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of pancreatic polypeptide family peptides on feeding and learning behavior in mice.
    Nakajima M; Inui A; Teranishi A; Miura M; Hirosue Y; Okita M; Himori N; Baba S; Kasuga M
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1010-4. PubMed ID: 8113957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Central stimulation of oxytocin release in the lactating rat: interaction of neuropeptide Y with alpha-1-adrenergic mechanisms.
    Parker SL; Crowley WR
    Endocrinology; 1993 Feb; 132(2):658-66. PubMed ID: 8381069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of neuropeptide Y on the hypothalamic-pituitary-adrenal axis in the dog.
    Inoue T; Inui A; Okita M; Sakatani N; Oya M; Morioka H; Mizuno N; Oimomi M; Baba S
    Life Sci; 1989; 44(15):1043-51. PubMed ID: 2538698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of a Y1-preferring NPY/PYY receptor in HT-29 cells.
    Mannon PJ; Mervin SJ; Sheriff-Carter KD
    Am J Physiol; 1994 Nov; 267(5 Pt 1):G901-7. PubMed ID: 7977753
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Leu31-Pro34] neuropeptide Y identifies a subtype of 125I-labeled peptide YY binding sites in the rat brain.
    Gehlert DR; Gackenheimer SL; Schober DA
    Neurochem Int; 1992 Jul; 21(1):45-67. PubMed ID: 1303142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuromodulation of the cardiac vagus: comparison of neuropeptide Y and related peptides.
    Kilborn MJ; Potter EK; McCloskey DI
    Regul Pept; 1985 Oct; 12(2):155-61. PubMed ID: 2866566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Syntheses and receptor affinities of partial sequences of peptide YY (PYY).
    Balasubramaniam A; Servin AL; Rigel DF; Rouyer-Fessard CR; Laburthe M
    Pept Res; 1988; 1(1):32-5. PubMed ID: 2856553
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opposite effects of neuropeptide Y (NPY) and polypeptide YY (PYY) on plasma immunoreactive atrial natriuretic factor (IR-ANF) in rats.
    Baranowska B; Gutkowska J; Lemire A; Cantin M; Genest J
    Biochem Biophys Res Commun; 1987 Jun; 145(2):680-5. PubMed ID: 2954552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peptide YY reduces effects of sympathetic nerves and neuropeptide Y on cardiac vagal action.
    Potter EK; McCloskey DI
    Peptides; 1991; 12(4):805-8. PubMed ID: 1788144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide.
    Larhammar D
    Regul Pept; 1996 Apr; 62(1):1-11. PubMed ID: 8738876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.